Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Schlickeiser

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Nature Neuroscience|December 19, 2018
Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometryChotima Böttcher, Stephan Schlickeiser, Marjolein A M Sneeboer, et al.
Science Translational Medicine|January 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancerTino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Infection|February 7, 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceJulia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, et al.
Frontiers in Immunology|November 30, 2019
Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional PropertiesAnastazja Andrzejewska, Rusan Catar, Janosch Schoon, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
Science Advances|May 21, 2025
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cellsPhillip Schiele, Alberto Sada Japp, Regina Stark, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
Science Advances|September 4, 2024
Effector memory-type regulatory T cells display phenotypic and functional instabilityDésirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Nature Neuroscience|December 19, 2018
Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometryChotima Böttcher, Stephan Schlickeiser, Marjolein A M Sneeboer, et al.
Science Translational Medicine|January 14, 2021
The intratumoral CXCR3 chemokine system is predictive of chemotherapy response in human bladder cancerTino Vollmer, Stephan Schlickeiser, Leila Amini, et al.
Infection|February 7, 2024
Persistent immune abnormalities discriminate post-COVID syndrome from convalescenceJulia Sbierski-Kind, Stephan Schlickeiser, Svenja Feldmann, et al.
Frontiers in Immunology|November 30, 2019
Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional PropertiesAnastazja Andrzejewska, Rusan Catar, Janosch Schoon, et al.
BMJ (Clinical Research Ed.)|October 22, 2020
Regulatory T cells for minimising immune suppression in kidney transplantation: phase I/IIa clinical trialAndy Roemhild, Natalie Maureen Otto, Guido Moll, et al.
JCI Insight|December 7, 2018
A standardized immune phenotyping and automated data analysis platform for multicenter biomarker studiesSabine Ivison, Mehrnoush Malek, Rosa V Garcia, et al.
Science Advances|May 21, 2025
CD8<sup>+</sup> T cell-derived CD40L mediates noncanonical cytotoxicity in CD40-expressing cancer cellsPhillip Schiele, Alberto Sada Japp, Regina Stark, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 10, 2020
Feasibility, long-term safety, and immune monitoring of regulatory T cell therapy in living donor kidney transplant recipientsPaul N Harden, David S Game, Birgit Sawitzki, et al.
Science Advances|September 4, 2024
Effector memory-type regulatory T cells display phenotypic and functional instabilityDésirée Jacqueline Wendering, Leila Amini, Stephan Schlickeiser, et al.
Molecular Therapy. Advances|May 18, 2026
Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulationGhazaleh Zarrinrad, Lisa-Marie Burkhardt, Claudia Beltran-Mestres, et al.
Pageof 7